| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acknowledgements
|
|
|
|
178 |
1-2 |
p. 1-2
|
article
|
| 2 |
Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis
|
Oumerzouk, J.
|
|
|
178 |
1-2 |
p. 144-150
|
article
|
| 3 |
CONFISEP: Impact of the Covid-19 pandemic lockdown on patients with multiple sclerosis in the north of France
|
Donzé, C.
|
|
|
178 |
1-2 |
p. 151-155
|
article
|
| 4 |
Contents
|
|
|
|
178 |
1-2 |
p. iv-v
|
article
|
| 5 |
COVID-19: A putative trigger for neuralgic amyotrophy
|
Balloy, G.
|
|
|
178 |
1-2 |
p. 157-158
|
article
|
| 6 |
Delayed awakening in neurocritical care
|
Bouchereau, E.
|
|
|
178 |
1-2 |
p. 21-33
|
article
|
| 7 |
Diagnosing SARS-CoV-2 vaccination associated aseptic meningitis is intricate
|
Finsterer, J.
|
|
|
178 |
1-2 |
p. 156-157
|
article
|
| 8 |
Editorial
|
Azulay, J.-P.
|
|
|
178 |
1-2 |
p. 3
|
article
|
| 9 |
Editorial
|
Couratier, P.
|
|
|
178 |
1-2 |
p. 4
|
article
|
| 10 |
Editorial Board
|
|
|
|
178 |
1-2 |
p. i
|
article
|
| 11 |
Ethical issues in neurocritical care
|
Perrigault, P.F.
|
|
|
178 |
1-2 |
p. 57-63
|
article
|
| 12 |
Immunomodulation in the acute phase of autoimmune encephalitis
|
Ciano-Petersen, N.L.
|
|
|
178 |
1-2 |
p. 34-47
|
article
|
| 13 |
Intensive care management of patients with viral encephalitis
|
Sonneville, R.
|
|
|
178 |
1-2 |
p. 48-56
|
article
|
| 14 |
Intensive care unit-acquired weakness: Questions the clinician should ask
|
Tortuyaux, R.
|
|
|
178 |
1-2 |
p. 84-92
|
article
|
| 15 |
Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients
|
Chaumont, H.
|
|
|
178 |
1-2 |
p. 137-143
|
article
|
| 16 |
Neurocritical care for neurological incapacitated patients
|
Ben Hadj Salem, O.
|
|
|
178 |
1-2 |
p. 105-110
|
article
|
| 17 |
New onset refractory status epilepticus: State of the art
|
Périn, B.
|
|
|
178 |
1-2 |
p. 74-83
|
article
|
| 18 |
Parvovirus B19-related peripheral nerve necrotizing vasculitis following SARS-CoV-2 infection
|
Fargeot, G.
|
|
|
178 |
1-2 |
p. 158-160
|
article
|
| 19 |
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis
|
Etemadifar, M.
|
|
|
178 |
1-2 |
p. 121-128
|
article
|
| 20 |
Serge Brion (1921–2021)
|
Lechevalier, B.
|
|
|
178 |
1-2 |
p. 5-6
|
article
|
| 21 |
Shaping the future of neurocritical care in France
|
Rohaut, B.
|
|
|
178 |
1-2 |
p. 7-8
|
article
|
| 22 |
Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine
|
Reis Carneiro, D.
|
|
|
178 |
1-2 |
p. 160-161
|
article
|
| 23 |
The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19
|
Fathi, M.
|
|
|
178 |
1-2 |
p. 129-136
|
article
|
| 24 |
The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
|
Balança, B.
|
|
|
178 |
1-2 |
p. 64-73
|
article
|
| 25 |
Toward a coherent structuration of disorders of consciousness expertise at a country scale: A proposal for France
|
Naccache, L.
|
|
|
178 |
1-2 |
p. 9-20
|
article
|
| 26 |
Toxic-metabolic encephalopathy in adults: Critical discussion and pragmatical diagnostic approach
|
Le Guennec, L.
|
|
|
178 |
1-2 |
p. 93-104
|
article
|
| 27 |
Weaning from mechanical ventilation in neurocritical care
|
Bureau, C.
|
|
|
178 |
1-2 |
p. 111-120
|
article
|
Journal description